ArticleClinical rheumatology2025

Letter to the Editor: Assessing early therapeutic drug monitoring of adalimumab as a predictor of treatment efficacy and immunogenicity in rheumatic diseases: "early therapeutic drug monitoring of adalimumab".

Syeda Hani Ammad et al.PubMed ↗Publisher ↗

No numbers read from the abstract.